Now showing items 1-10 of 72
Pharmacologic management of perioperative pulmonary hypertension.
(J Cardiovasc Pharmacol, 2014-04)
Perioperative pulmonary hypertension can originate from an established disease or acutely develop within the surgical setting. Patients with increased pulmonary vascular resistance are consequently at greater risk ...
Association of anemia and long-term survival in patients with pulmonary hypertension.
(Int J Cardiol, 2011-08-04)
BACKGROUND: Anemia is a marker of worsened clinical outcome in patients with heart failure from left ventricular dysfunction. Pulmonary hypertension often results in right ventricular dysfunction. Accordingly we sought to ...
Right-sided heart catheterization: de rigueur in sarcoidosis?
Two Cases of Late Shone Syndrome With Pulmonary Hypertension: Heart-Lung Transplant or Valve Surgery?
(World J Pediatr Congenit Heart Surg, 2016-01)
Two cases of Shone syndrome with severe mitral and aortic valve problems and pulmonary hypertension were referred for heart-lung transplantation. Severely elevated pulmonary vascular resistance (PVR) was confirmed as was ...
Inhaled treprostinil sodium for pulmonary hypertension
(Expert Opinion on Orphan Drugs, 2014-01-01)
Introduction: Pulmonary arterial hypertension is an increasingly recognized heterogeneous disease with significant morbidity and mortality, requiring a multimodal approach to treatment. Inhalation administration of treprostinil ...
Safety and Use of Anticoagulation After Aortic Valve Replacement With Bioprostheses: A Meta-Analysis.
(Circ Cardiovasc Qual Outcomes, 2016-05)
BACKGROUND: The American College of Cardiology guidelines recommend 3 months of anticoagulation after replacement of the aortic valve with a bioprosthesis. However, there remains great variability in the current clinical ...
Downstream coronary effects of drug-eluting stents.
(Am Heart J, 2011-10)
BACKGROUND: Antiproliferative agents used in drug-eluting stents (DES) attenuate atherosclerosis, yet DES implantation has been linked to endothelial dysfunction. The downstream effects of DES on new lesion formation have ...
Response to inhaled nitric oxide predicts survival in patients with pulmonary hypertension.
(J Card Fail, 2011-04)
OBJECTIVE: To examine the ability of vasodilator response to predict survival in a diverse cohort of patients with pulmonary hypertension (PH). PATIENTS & METHODS: A total of 214 consecutive treatment-naive patients referred ...
Conflicts of Interest and Outcomes of Cardiovascular Trials.
(Am J Cardiol, 2016-03-01)
Conflicts of interests have long been recognized as potential sources of influence in the conduct and reporting of clinical trials. This controversy was again rekindled after the publication of the latest statin guidelines ...
Should Physicians be Encouraged to use Generic Names and to Prescribe Generic Drugs?
(Am J Cardiol, 2016-06-01)
While using the brand names seems like a trivial issue at the outset, using these names is inherently problematic. Cardiovascular drugs remain the most commonly prescribed drugs by the physicians. The junior doctors are ...